Methacrylic Acid

Methacrylic Acid

SCHEMBL787502

C1CO1.C=C(C)C(=O)O.CC1CO1

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL28598224 1.00 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2TDP1
Methacrylic Acid SCHEMBL2877273 1.00 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2TDP1
Methacrylic Acid SCHEMBL2580492 1.00 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2TDP1
Methacrylic Acid SCHEMBL2577136 1.00 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2TDP1
Methacrylic Acid SCHEMBL8979408 0.93 ALDH1A1 (0.42) ALDH1A1TDP1
Methacrylic Acid SCHEMBL3432713 0.93 ALDH1A1 (0.42) ALDH1A1TDP1
Methacrylic Acid SCHEMBL163822 0.93 ALDH1A1 (0.42) ALDH1A1TDP1
Methacrylic Acid SCHEMBL29284830 0.91 ALDH1A1 (0.41) ALDH1A1TDP1
Methacrylic Acid SCHEMBL15636144 0.91 ALDH1A1 (0.41) ALDH1A1TDP1
Methacrylic Acid SCHEMBL2575784 0.90 ALDH1A1 (0.35) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616106-B1 ANTIMICROBIAL DISPOSABLE ABSORBENT ARTICLES 3M INNOVATIVE PROPERTIES CO (US) 2017-12-06 EP disclosed
EP-2462956-B2 Absorbent medical articles 3M INNOVATIVE PROPERTIES CO (US) 2017-03-29 EP disclosed
EP-1897566-B1 Gel materials, medical articles, and methods 3M INNOVATIVE PROPERTIES CO (US) 2017-02-22 EP disclosed
US-9522211-B2 Antimicrobial disposable absorbent articles 3M INNOVATIVE PROPERTIES CO (US) 2016-12-20 US disclosed
EP-1572254-B1 ABSORBENT MEDICAL ARTICLES 3M INNOVATIVE PROPERTIES CO (US) 2015-11-04 EP disclosed
US-20150010478-A1 ANTIMICROBIAL DISPOSABLE ABSORBENT ARTICLES 3M INNOVATIVE PROPERTIES CO (US) 2015-01-08 US disclosed
US-8598291-B2 Antifouling composition, method for its production and article treated therewith ASAHI GLASS COMPANY, LIMITED (JP) 2013-12-03 US disclosed
EP-2616106-A1 ANTIMICROBIAL DISPOSABLE ABSORBENT ARTICLES 3M Innovative Properties Company (US) 2013-07-24 EP disclosed
US-20130165880-A1 ANTIMICROBIAL DISPOSABLE ABSORBENT ARTICLES 3M INNOVATIVE PROPERTIES COMPANY 2013-06-27 US disclosed
US-8410332-B2 Absorbent medical articles 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-04-02 US disclosed
WO-2005092403-A1 HYDROPHILIC MATERIALS FROM REACTIVE OLIGOMERS HAVING PHOTOINITIATOR GROUPS 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-10-06 WO disclosed
WO-2005092402-A1 CROSSLINKABLE HYDROPHILIC MATERIALS FROM REACTIVE OLIGOMERS HAVING PENDENT UNSATURATED GROUPS 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-10-06 WO disclosed
EP-1572254-A1 ABSORBENT MEDICAL ARTICLES 3M Innovative Properties Company (US) 2005-09-14 EP disclosed
US-20050194559-A1 Crosslinkable hydrophilic materials from reactive oligomers having pendent unsaturated groups 3M INNOVATIVE PROPERTIES COMPANY 2005-09-08 US disclosed
US-20050192370-A1 Crosslinkable hydrophilic materials from reactive oligomers having pendent photoinitiator groups 3M INNOVATIVE PROPERTIES COMPANY 2005-09-01 US disclosed
EP-1494727-A1 GEL MATERIALS, MEDICAL ARTICLES, AND METHODS 3M Innovative Properties Company (US) 2005-01-12 EP disclosed
WO-2004060413-A1 ABSORBENT MEDICAL ARTICLES 3M INNOVATIVE PROPERTIES COMPANY (US) 2004-07-22 WO disclosed
US-20040133143-A1 Absorbent medical articles 3M INNOVATIVE PROPERTIES COMPANY 2004-07-08 US disclosed
US-20030203011-A1 Gel materials, medical articles, and methods 3M INNOVATIVE PROPERTIES COMPANY 2003-10-30 US disclosed
WO-2003086493-A1 GEL MATERIALS, MEDICAL ARTICLES, AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203011-A1 Gel materials, medical articles, and methods PTGES, PTGS2, PTGIS ALDH1A1 1247/4885SMN1; SMN2 2820/4885TDP1 2305/4885
US-20130165880-A1 ANTIMICROBIAL DISPOSABLE ABSORBENT ARTICLES CUTA, PCNA, ITCH ALDH1A1 88/4885SMN1; SMN2 842/4885TDP1 4394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.